Literature DB >> 11375937

Rescue of the early vascular defects in Tek/Tie2 null mice reveals an essential survival function.

N Jones1, D Voskas, Z Master, R Sarao, J Jones, D J Dumont.   

Abstract

Disruption of the signaling pathways mediated by the receptor tyrosine kinase Tek/Tie2 has shown that this receptor plays a pivotal role in vascularization of the developing embryo. In this report, we have utilized the tetracycline-responsive binary transgenic system to overcome the early lethal cardiovascular defects associated with the tekDeltasp null allele in order to investigate the role of Tek in later stages of vessel growth. We show for the first time in vivo that synchronized loss of tek expression correlates with rapid endothelial cell apoptosis in hemorrhagic regions of the embryo, demonstrating an ongoing requirement for Tek-mediated signal transduction in vascular maintenance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11375937      PMCID: PMC1083887          DOI: 10.1093/embo-reports/kve093

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  20 in total

1.  Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation.

Authors:  T N Sato; Y Tozawa; U Deutsch; K Wolburg-Buchholz; Y Fujiwara; M Gendron-Maguire; T Gridley; H Wolburg; W Risau; Y Qin
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

Review 2.  Blood vessel formation: what is its molecular basis?

Authors:  J Folkman; P A D'Amore
Journal:  Cell       Date:  1996-12-27       Impact factor: 41.582

3.  Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-Kinase/Akt signal transduction pathway.

Authors:  I Kim; H G Kim; J N So; J H Kim; H J Kwak; G Y Koh
Journal:  Circ Res       Date:  2000 Jan 7-21       Impact factor: 17.367

4.  Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning.

Authors:  S Davis; T H Aldrich; P F Jones; A Acheson; D L Compton; V Jain; T E Ryan; J Bruno; C Radziejewski; P C Maisonpierre; G D Yancopoulos
Journal:  Cell       Date:  1996-12-27       Impact factor: 41.582

5.  Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis.

Authors:  C Suri; P F Jones; S Patan; S Bartunkova; P C Maisonpierre; S Davis; T N Sato; G D Yancopoulos
Journal:  Cell       Date:  1996-12-27       Impact factor: 41.582

6.  Identification of Tek/Tie2 binding partners. Binding to a multifunctional docking site mediates cell survival and migration.

Authors:  N Jones; Z Master; J Jones; D Bouchard; Y Gunji; H Sasaki; R Daly; K Alitalo; D J Dumont
Journal:  J Biol Chem       Date:  1999-10-22       Impact factor: 5.157

7.  Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development.

Authors:  D J Dumont; G H Fong; M C Puri; G Gradwohl; K Alitalo; M L Breitman
Journal:  Dev Dyn       Date:  1995-05       Impact factor: 3.780

8.  Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice.

Authors:  A Kistner; M Gossen; F Zimmermann; J Jerecic; C Ullmer; H Lübbert; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

9.  Transcriptional activation by tetracyclines in mammalian cells.

Authors:  M Gossen; S Freundlieb; G Bender; G Müller; W Hillen; H Bujard
Journal:  Science       Date:  1995-06-23       Impact factor: 47.728

10.  Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo.

Authors:  D J Dumont; G Gradwohl; G H Fong; M C Puri; M Gertsenstein; A Auerbach; M L Breitman
Journal:  Genes Dev       Date:  1994-08-15       Impact factor: 11.361

View more
  33 in total

1.  Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells.

Authors:  Akiyoshi Uemura; Minetaro Ogawa; Masanori Hirashima; Takashi Fujiwara; Shinji Koyama; Hitoshi Takagi; Yoshihito Honda; Stanley J Wiegand; George D Yancopoulos; Shin-Ichi Nishikawa
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

2.  Brain pericytes: emerging concepts and functional roles in brain homeostasis.

Authors:  Masahiro Kamouchi; Tetsuro Ago; Takanari Kitazono
Journal:  Cell Mol Neurobiol       Date:  2011-03       Impact factor: 5.046

3.  Depletion of antigen-presenting cells by clodronate liposomes reverses the psoriatic skin phenotype in KC-Tie2 mice.

Authors:  N L Ward; C M Loyd; J A Wolfram; D Diaconu; C M Michaels; T S McCormick
Journal:  Br J Dermatol       Date:  2011-04       Impact factor: 9.302

4.  Loss of Tie2 receptor compromises embryonic stem cell-derived endothelial but not hematopoietic cell survival.

Authors:  Isao Hamaguchi; Tohru Morisada; Masaki Azuma; Kyoko Murakami; Madoka Kuramitsu; Takuo Mizukami; Kazuyuki Ohbo; Kazunari Yamaguchi; Yuichi Oike; Daniel J Dumont; Toshio Suda
Journal:  Blood       Date:  2005-10-11       Impact factor: 22.113

5.  Activated protein C binds directly to Tie2: possible beneficial effects on endothelial barrier function.

Authors:  Nikita Minhas; Meilang Xue; Christopher J Jackson
Journal:  Cell Mol Life Sci       Date:  2016-12-22       Impact factor: 9.261

6.  Hematopoiesis and stem cell renewal in long-term bone marrow cultures containing catalase.

Authors:  Rashmi Gupta; Simon Karpatkin; Ross S Basch
Journal:  Blood       Date:  2005-11-08       Impact factor: 22.113

7.  Cutaneous manipulation of vascular growth factors leads to alterations in immunocytes, blood vessels and nerves: Evidence for a cutaneous neurovascular unit.

Authors:  Nicole L Ward; Denise A Hatala; Julie A Wolfram; Dorothy A Knutsen; Candace M Loyd
Journal:  J Dermatol Sci       Date:  2010-11-13       Impact factor: 4.563

8.  A cyclosporine-sensitive psoriasis-like disease produced in Tie2 transgenic mice.

Authors:  Daniel Voskas; Nina Jones; Paul Van Slyke; Celina Sturk; Wing Chang; Alex Haninec; Yael Olya Babichev; Jennifer Tran; Zubin Master; Stephen Chen; Nicole Ward; Maribelle Cruz; Jamie Jones; Robert S Kerbel; Serge Jothy; Lina Dagnino; Jack Arbiser; Giannoula Klement; Daniel J Dumont
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

9.  Angiopoietin-1 causes reversible degradation of the portal microcirculation in mice: implications for treatment of liver disease.

Authors:  Nicole L Ward; Alexandra L Haninec; Paul Van Slyke; John G Sled; Celina Sturk; R Mark Henkelman; Ian R Wanless; Daniel J Dumont
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

10.  Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor FKHR (FOXO1).

Authors:  Christopher Daly; Vivian Wong; Elena Burova; Yi Wei; Stephanie Zabski; Jennifer Griffiths; Ka-Man Lai; Hsin Chieh Lin; Ella Ioffe; George D Yancopoulos; John S Rudge
Journal:  Genes Dev       Date:  2004-05-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.